1
|
Moroni AB, Calvo NL, Kaufman TS. Selected Aspects of the Analytical and Pharmaceutical Profiles of Nifurtimox. J Pharm Sci 2023; 112:1523-1538. [PMID: 36822273 DOI: 10.1016/j.xphs.2023.02.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2023] [Revised: 02/16/2023] [Accepted: 02/16/2023] [Indexed: 02/24/2023]
Abstract
Nifurtimox is a nitroheterocyclic drug employed for treatment of trypanosomiases (Chagas disease and West African sleeping sickness); its use for certain cancers has also been assessed. Despite having been in the market for over 50 years, knowledge of nifurtimox is still fragmentary and incomplete. Relevant aspects of the chemistry and biology of nifurtimox are reviewed to summarize the current knowledge of this drug. These comprise its chemical synthesis and the preparation of some analogues, as well as its chemical degradation. Selected physical data and physicochemical properties are also listed, along with different approaches toward the analytical characterization of the drug, including electrochemical (polarography, cyclic voltammetry), spectroscopic (ultraviolet-visible, nuclear magnetic resonance, electron spin resonance), and single crystal X-ray diffractometry. The array of polarographic, ultraviolet-visible spectroscopic, and chromatographic methods available for the analytical determination of nifurtimox (in bulk drug, pharmaceutical formulations, and biological samples), are also presented and discussed, along with chiral chromatographic and electrophoretic alternatives for the separation of the enantiomers of the drug. Aspects of the drug likeliness of nifurtimox, its classification in the Biopharmaceutical Classification System, and available pharmaceutical formulations are detailed, whereas pharmacological, chemical, and biological aspects of its metabolism and disposition are discussed.
Collapse
Affiliation(s)
- Aldana B Moroni
- Área de Análisis de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario e Instituto de Química Rosario (IQUIR, CONICET-UNR), Suipacha 531, Rosario S2002LRK, Argentina
| | - Natalia L Calvo
- Área de Análisis de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario e Instituto de Química Rosario (IQUIR, CONICET-UNR), Suipacha 531, Rosario S2002LRK, Argentina
| | - Teodoro S Kaufman
- Área de Análisis de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario e Instituto de Química Rosario (IQUIR, CONICET-UNR), Suipacha 531, Rosario S2002LRK, Argentina.
| |
Collapse
|
2
|
Guedes JS, Carneiro TR, Pinheiro PDSM, Fraga CA, Sant′Anna CM, Barreiro EJ, Lima LM. Methyl Effect on the Metabolism, Chemical Stability, and Permeability Profile of Bioactive N-Sulfonylhydrazones. ACS OMEGA 2022; 7:38752-38765. [PMID: 36340078 PMCID: PMC9631887 DOI: 10.1021/acsomega.2c04368] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Accepted: 10/10/2022] [Indexed: 06/16/2023]
Abstract
Sulfonylhydrazones are privileged structures with multifaceted pharmacological activity. Exploring the hypoglycemic properties of these organic compounds, we previously revealed a new series of N-sulfonylhydrazones (NSH) as antidiabetic drug candidates. Here, we evaluated the microsomal metabolism, chemical stability, and permeability profile of these NSH prototypes, focusing on the pharmacokinetic differences in N-methylated and non-N-methylated analogs. Our results demonstrated that the N-methylated analogs (LASSBio-1772 and LASSBio-1774) were metabolized by CYP, forming three and one metabolites, respectively. These prototypes exhibited chemical stability at pH 2.0 and 7.4 and brain penetration ability. On the other hand, non-N-methylated analogs (LASSBio-1771 and LASSBio-1773) were hydrolyzed in acid pH and could not cross the artificial blood-brain barrier. The cyano group in LASSBio-1771 was postulated as a possible site of interaction with the heme group, potentially inhibiting CYP enzymes. Moreover, prototypes with the methyl ester group were metabolized by carboxylesterase, and non-N-methylated analogs did not show oxidative metabolism. The prototypes (except LASSBio-1774) showed excellent gastrointestinal absorption. Altogether, our data support the idea that the methyl effect on NSH strongly alters their pharmacokinetic profile, enhances the recognition by CYP enzymes, promotes brain penetration, and plays a protective effect upon acid hydrolysis.
Collapse
Affiliation(s)
- Jéssica
de Siqueira Guedes
- Instituto
Nacional de Ciência e Tecnologia de Fármacos e Medicamentos
(INCT-INOFAR), Laboratório de Avaliação e Síntese
de Substâncias Bioativas (LASSBio), Universidade Federal do Rio de Janeiro (UFRJ), CCS, Cidade Universitária, Rio de Janeiro-RJ 21941-902, Brazil
- Pós-graduação
em Química, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro-RJ 21941-909, Brazil
| | - Teiliane Rodrigues Carneiro
- Instituto
Nacional de Ciência e Tecnologia de Fármacos e Medicamentos
(INCT-INOFAR), Laboratório de Avaliação e Síntese
de Substâncias Bioativas (LASSBio), Universidade Federal do Rio de Janeiro (UFRJ), CCS, Cidade Universitária, Rio de Janeiro-RJ 21941-902, Brazil
| | - Pedro de Sena Murteira Pinheiro
- Instituto
Nacional de Ciência e Tecnologia de Fármacos e Medicamentos
(INCT-INOFAR), Laboratório de Avaliação e Síntese
de Substâncias Bioativas (LASSBio), Universidade Federal do Rio de Janeiro (UFRJ), CCS, Cidade Universitária, Rio de Janeiro-RJ 21941-902, Brazil
| | - Carlos Alberto
Manssour Fraga
- Instituto
Nacional de Ciência e Tecnologia de Fármacos e Medicamentos
(INCT-INOFAR), Laboratório de Avaliação e Síntese
de Substâncias Bioativas (LASSBio), Universidade Federal do Rio de Janeiro (UFRJ), CCS, Cidade Universitária, Rio de Janeiro-RJ 21941-902, Brazil
- Pós-graduação
em Química, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro-RJ 21941-909, Brazil
| | - Carlos Mauricio
R. Sant′Anna
- Instituto
Nacional de Ciência e Tecnologia de Fármacos e Medicamentos
(INCT-INOFAR), Laboratório de Avaliação e Síntese
de Substâncias Bioativas (LASSBio), Universidade Federal do Rio de Janeiro (UFRJ), CCS, Cidade Universitária, Rio de Janeiro-RJ 21941-902, Brazil
- Departamento
de Química, Instituto de Ciências Exatas, Universidade Federal Rural do Rio de Janeiro (UFRRJ), Seropédica 23970-000, Brazil
| | - Eliezer J. Barreiro
- Instituto
Nacional de Ciência e Tecnologia de Fármacos e Medicamentos
(INCT-INOFAR), Laboratório de Avaliação e Síntese
de Substâncias Bioativas (LASSBio), Universidade Federal do Rio de Janeiro (UFRJ), CCS, Cidade Universitária, Rio de Janeiro-RJ 21941-902, Brazil
- Pós-graduação
em Química, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro-RJ 21941-909, Brazil
| | - Lídia Moreira Lima
- Instituto
Nacional de Ciência e Tecnologia de Fármacos e Medicamentos
(INCT-INOFAR), Laboratório de Avaliação e Síntese
de Substâncias Bioativas (LASSBio), Universidade Federal do Rio de Janeiro (UFRJ), CCS, Cidade Universitária, Rio de Janeiro-RJ 21941-902, Brazil
- Pós-graduação
em Química, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro-RJ 21941-909, Brazil
| |
Collapse
|
3
|
de Aquino TM, França PHB, Rodrigues ÉEES, Nascimento IJS, Santos-Júnior PFS, Aquino PGV, Santos MS, Queiroz AC, Araújo MV, Alexandre-Moreira MS, Rodrigues RRL, Rodrigues KAF, Freitas JD, Bricard J, Meneghetti MR, Bourguignon JJ, Schmitt M, da Silva-Júnior EF, de Araújo-Júnior JX. Synthesis, Antileishmanial Activity and in silico Studies of Aminoguanidine Hydrazones (AGH) and Thiosemicarbazones (TSC) Against Leishmania chagasi Amastigotes. Med Chem 2021; 18:151-169. [PMID: 33593264 DOI: 10.2174/1573406417666210216154428] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Revised: 12/14/2020] [Accepted: 12/15/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND Leishmaniasis is a worldwide health problem, highly endemic in developing countries. Among the four main clinical forms of the disease, visceral leishmaniasis is the most severe, fatal in 95% of cases. The undesired side-effects from first-line chemotherapy and the reported drug resistance search for effective drugs that can replace or supplement those currently used an urgent need. Aminoguanidine hydrazones (AGH's) have been explored for exhibiting a diverse spectrum of biological activities, in particular the antileishmanial activity of MGBG. The bioisosteres thiosemicarbazones (TSC's) offer a similar biological activity diversity, including antiprotozoal effects against Leishmania species and Trypanosoma cruzi. OBJECTIVE Considering the impact of leishmaniasis worldwide, this work aimed to design, synthesize, and perform a screening upon L. chagasi amastigotes and for the cytotoxicity of the small "in-house" library of both AGH and TSC derivatives and their structurally-related compounds. METHOD A set of AGH's (3-7), TSC's (9, 10), and semicarbazones (11) were initially synthesized. Subsequently, different semi-constrained analogs were designed and also prepared, including thiazolidines (12), dihydrothiazines (13), imidazolines (15), pyrimidines (16, 18) azines (19, 20), and benzotriazepinones (23-25). All intermediates and target compounds were obtained with satisfactory yields and exhibited spectral data consistent with their structures. All final compounds were evaluated against L. chagasi amastigotes and J774.A1 cell line. Molecular docking was performed towards trypanothione reductase using GOLD® software. RESULT The AGH's 3i, 4a, and 5d, and the TSC's 9i, 9k, and 9o were selected as valuable hits. These compounds presented antileishmanial activity compared with pentamidine, showing IC50 values ranged from 0.6 to 7.27 μM, maximal effects up to 55.3%, and satisfactory SI values (ranged from 11 to 87). On the other hand, most of the resulting semi-constrained analogs were found cytotoxic or presented reduced antileishmanial activity. In general, TSC class is more promising than its isosteric AGH analogs, and the beneficial aromatic substituent effects are not similar in both series. In silico studies have suggested that these hits are capable of inhibiting the trypanothione reductase from the amastigote forms. CONCLUSION The promising antileishmanial activity of three AGH's and three TSC's was characterized. These compounds presented antileishmanial activity compared with PTD, showing IC50 values ranged from 0.6 to 7.27 μM, and satisfactory SI values. Further pharmacological assays involving other Leishmania strains are under progress, which will help to choose the best hits for in vivo experiments.
Collapse
Affiliation(s)
- Thiago M de Aquino
- Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, 57072-900, Maceió-AL. Brazil
| | - Paulo H B França
- Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, 57072-900, Maceió-AL. Brazil
| | - Érica E E S Rodrigues
- Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, 57072-900, Maceió-AL. Brazil
| | - Igor J S Nascimento
- Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, 57072-900, Maceió-AL. Brazil
| | - Paulo F S Santos-Júnior
- Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, 57072-900, Maceió-AL. Brazil
| | - Pedro G V Aquino
- Federal Rural University of Pernambuco, Garanhuns-PE, 55292-270. Brazil
| | - Mariana S Santos
- Federal Rural University of Pernambuco, Garanhuns-PE, 55292-270. Brazil
| | - Aline C Queiroz
- Laboratory of Pharmacology and Immunology, Institute of Biological and Health Sciences, Federal University of Alagoas, 57072-900, Maceió-AL. Brazil
| | - Morgana V Araújo
- Laboratory of Pharmacology and Immunology, Institute of Biological and Health Sciences, Federal University of Alagoas, 57072-900, Maceió-AL. Brazil
| | - Magna S Alexandre-Moreira
- Laboratory of Pharmacology and Immunology, Institute of Biological and Health Sciences, Federal University of Alagoas, 57072-900, Maceió-AL. Brazil
| | - Raiza R L Rodrigues
- Laboratory of Infectious Diseases, Federal University of Parnaíba Delta, 64202-020, Parnaíba-PI. Brazil
| | - Klinger A F Rodrigues
- Laboratory of Infectious Diseases, Federal University of Parnaíba Delta, 64202-020, Parnaíba-PI. Brazil
| | - Johnnatan D Freitas
- Instrumental Analysis Laboratory, Federal Institute of Alagoas, Campus Maceió, Ferroviário Avenue, 57020-600, Maceió-AL. Brazil
| | - Jacques Bricard
- Laboratoire d'Innovation thérapeutique, UMR 7200, Labex Medalis, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401 Illkirch. France
| | - Mario R Meneghetti
- Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-90 0, Maceió-AL. Brazil
| | - Jean-Jacques Bourguignon
- Laboratoire d'Innovation thérapeutique, UMR 7200, Labex Medalis, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401 Illkirch. France
| | - Martine Schmitt
- Laboratoire d'Innovation thérapeutique, UMR 7200, Labex Medalis, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401 Illkirch. France
| | - Edeildo F da Silva-Júnior
- Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, 57072-900, Maceió-AL. Brazil
| | - João X de Araújo-Júnior
- Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, 57072-900, Maceió-AL. Brazil
| |
Collapse
|
4
|
da S M Forezi L, Lima CGS, Amaral AAP, Ferreira PG, de Souza MCBV, Cunha AC, de C da Silva F, Ferreira VF. Bioactive 1,2,3-Triazoles: An Account on their Synthesis, Structural Diversity and Biological Applications. CHEM REC 2021; 21:2782-2807. [PMID: 33570242 DOI: 10.1002/tcr.202000185] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Revised: 01/28/2021] [Accepted: 01/29/2021] [Indexed: 12/14/2022]
Abstract
The triazole heterocycle is a privileged scaffold in medicinal chemistry, since its structure is present in a large number of biologically active molecules, including several drugs currently in the market. Due to their vast applications, a wide variety of methods are described for their preparation, such as the 1,3-dipolar cycloaddition and processes involving diazo compounds and diazo transfer reactions. Considering the significant number of contributions from our research group to this chemistry in recent decades, in this account we discuss both the development of new methods for the synthesis of 1,2,3-triazoles and the preparation of new triazole-functionalized biologically active molecules using classical approaches.
Collapse
Affiliation(s)
- Luana da S M Forezi
- Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Campus do Valonguinho, 24020-150, Niterói, RJ, Brazil
| | - Carolina G S Lima
- Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Campus do Valonguinho, 24020-150, Niterói, RJ, Brazil
| | - Adriane A P Amaral
- Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Campus do Valonguinho, 24020-150, Niterói, RJ, Brazil
| | - Patricia G Ferreira
- Departamento de Tecnologia Farmacêutica, Faculdade de Farmácia, Universidade Federal Fluminense, R. Dr. Mario Vianna, 523 - Santa Rosa, 24241-000, Niterói, RJ, Brazil
| | - Maria Cecília B V de Souza
- Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Campus do Valonguinho, 24020-150, Niterói, RJ, Brazil
| | - Anna C Cunha
- Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Campus do Valonguinho, 24020-150, Niterói, RJ, Brazil
| | - Fernando de C da Silva
- Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Campus do Valonguinho, 24020-150, Niterói, RJ, Brazil
| | - Vitor F Ferreira
- Departamento de Tecnologia Farmacêutica, Faculdade de Farmácia, Universidade Federal Fluminense, R. Dr. Mario Vianna, 523 - Santa Rosa, 24241-000, Niterói, RJ, Brazil
| |
Collapse
|
5
|
Jia X, Liu Q, Wang S, Zeng B, Du G, Zhang C, Li Y. Synthesis, cytotoxicity, and in vivo antitumor activity study of parthenolide semicarbazones and thiosemicarbazones. Bioorg Med Chem 2020; 28:115557. [DOI: 10.1016/j.bmc.2020.115557] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2020] [Revised: 04/29/2020] [Accepted: 05/05/2020] [Indexed: 12/23/2022]
|
6
|
Alves MA, de Queiroz AC, Leite AB, Martins FT, Doriguetto AC, Barreiro EJ, Alexandre-Moreira MS, Lima LM. Carbamoyl- N-aryl-imine-urea: a new framework to obtain a putative leishmanicidal drug-candidate. RSC Adv 2020; 10:12384-12394. [PMID: 35497630 PMCID: PMC9050848 DOI: 10.1039/d0ra00287a] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2020] [Accepted: 03/08/2020] [Indexed: 11/21/2022] Open
Abstract
Leishmaniasis is a neglected parasitic disease, and current treatment includes limitations of toxicity, variable efficacy, high costs and inconvenient doses and treatment schedules. Therefore, new leishmanicidal drugs are still an unquestionable medical need. In this paper we described the design conception of a new framework, the carbamoyl-N-aryl-imine-urea, to obtain putative leishmanicidal drug-candidates. Compounds 9a-e and 10a-e were designed and synthesized and their leishmanicidal activity was studied in comparison to pentamidine, miltefosine and meglumine antimoniate. The conformational profile of the new carbamoyl-N-aryl-imine-urea framework was investigated by X-ray diffraction studies, using compound 9a as a model. The plasma stability of this putative peptide mimetic subunit was studied for compound 10e (LASSBio-1736). Among the congeneric series, LASSBio-1736 was identified as a new antileishmanial drug-candidate, displaying plasma stability, cytotoxicity against amastigote forms of L. amazonensis and L. braziliensis, and leishmanicidal activity in a cutaneous leishmaniasis murine model, without preliminary evidence of hepatic or renal toxicity.
Collapse
Affiliation(s)
- Marina A Alves
- Instituto Nacional de Ciência e Tecnologia de Fármacos e Medicamentos (INCT-INOFAR), Laboratório de Avaliação e Síntese de Substâncias Bioativas (LASSBio, ®), Universidade Federal do Rio de Janeiro (UFRJ), CCS PO Box 68023, Cidade Universitária 21941-902 Rio de Janeiro RJ Brazil http://www.inct-inofar.ccs.ufrj.br http://www.lassbio.icb.ufrj.br.,Programa de Pós-graduação em Química, Instituto de Química, UFRJ 21941-909 Rio de Janeiro RJ Brazil
| | - Aline C de Queiroz
- Laboratório de Farmacologia e Imunologia, Instituto de Ciências Biológicas e da Saúde, Universidade Federal de Alagoas (UFAL) 57072-900 Maceió AL Brazil +55 82 3214 1528
| | - Anderson Brandão Leite
- Laboratório de Farmacologia e Imunologia, Instituto de Ciências Biológicas e da Saúde, Universidade Federal de Alagoas (UFAL) 57072-900 Maceió AL Brazil +55 82 3214 1528
| | - Felipe T Martins
- Instituto de Química, Universidade Federal de Goiás (UFG) Campus Samambaia, CP 131 Goiânia GO 74001-970 Brazil
| | - Antonio C Doriguetto
- Instituto de Química, Universidade Federal de Goiás (UFG) Campus Samambaia, CP 131 Goiânia GO 74001-970 Brazil
| | - Eliezer J Barreiro
- Instituto Nacional de Ciência e Tecnologia de Fármacos e Medicamentos (INCT-INOFAR), Laboratório de Avaliação e Síntese de Substâncias Bioativas (LASSBio, ®), Universidade Federal do Rio de Janeiro (UFRJ), CCS PO Box 68023, Cidade Universitária 21941-902 Rio de Janeiro RJ Brazil http://www.inct-inofar.ccs.ufrj.br http://www.lassbio.icb.ufrj.br.,Programa de Pós-graduação em Química, Instituto de Química, UFRJ 21941-909 Rio de Janeiro RJ Brazil
| | - Magna S Alexandre-Moreira
- Laboratório de Farmacologia e Imunologia, Instituto de Ciências Biológicas e da Saúde, Universidade Federal de Alagoas (UFAL) 57072-900 Maceió AL Brazil +55 82 3214 1528
| | - Lídia M Lima
- Instituto Nacional de Ciência e Tecnologia de Fármacos e Medicamentos (INCT-INOFAR), Laboratório de Avaliação e Síntese de Substâncias Bioativas (LASSBio, ®), Universidade Federal do Rio de Janeiro (UFRJ), CCS PO Box 68023, Cidade Universitária 21941-902 Rio de Janeiro RJ Brazil http://www.inct-inofar.ccs.ufrj.br http://www.lassbio.icb.ufrj.br.,Programa de Pós-graduação em Química, Instituto de Química, UFRJ 21941-909 Rio de Janeiro RJ Brazil
| |
Collapse
|
7
|
Balasubramaniyan S, Irfan N, Senthilkumar C, Umamaheswari A, Puratchikody A. The synthesis and biological evaluation of virtually designed fluoroquinolone analogs against fluoroquinolone-resistant Escherichia coliintended for UTI treatment. NEW J CHEM 2020. [DOI: 10.1039/d0nj00657b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Synthesis and evaluvate the supercoiling activity of the virtually screened novel fluoroquinolone analogs against fluoroquinolone-resistantEscherichia colifor the treatment of urinary tract infections (UTIs).
Collapse
Affiliation(s)
- Sakthivel Balasubramaniyan
- Drug Discovery and Development Research Group
- Department of Pharmaceutical Technology
- University College of Engineering
- Anna University
- BIT Campus
| | - Navabshan Irfan
- School of Pharmacy
- B.S. Abdur Rahman Crescent Institute of Science & Technology
- Chennai 600048
- India
| | | | - Appavoo Umamaheswari
- Drug Discovery and Development Research Group
- Department of Pharmaceutical Technology
- University College of Engineering
- Anna University
- BIT Campus
| | - Ayarivan Puratchikody
- Drug Discovery and Development Research Group
- Department of Pharmaceutical Technology
- University College of Engineering
- Anna University
- BIT Campus
| |
Collapse
|
8
|
Lee SM, Kim MS, Hayat F, Shin D. Recent Advances in the Discovery of Novel Antiprotozoal Agents. Molecules 2019; 24:E3886. [PMID: 31661934 PMCID: PMC6864685 DOI: 10.3390/molecules24213886] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Revised: 10/15/2019] [Accepted: 10/23/2019] [Indexed: 11/16/2022] Open
Abstract
Parasitic diseases have serious health, social, and economic impacts, especially in the tropical regions of the world. Diseases caused by protozoan parasites are responsible for considerable mortality and morbidity, affecting more than 500 million people worldwide. Globally, the burden of protozoan diseases is increasing and is been exacerbated because of a lack of effective medication due to the drug resistance and toxicity of current antiprotozoal agents. These limitations have prompted many researchers to search for new drugs against protozoan parasites. In this review, we have compiled the latest information (2012-2017) on the structures and pharmacological activities of newly developed organic compounds against five major protozoan diseases, giardiasis, leishmaniasis, malaria, trichomoniasis, and trypanosomiasis, with the aim of showing recent advances in the discovery of new antiprotozoal drugs.
Collapse
Affiliation(s)
- Seong-Min Lee
- College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Korea.
| | - Min-Sun Kim
- College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Korea.
| | - Faisal Hayat
- College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Korea.
| | - Dongyun Shin
- College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Korea.
| |
Collapse
|
9
|
Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis. Exp Parasitol 2019; 201:57-66. [PMID: 31004571 DOI: 10.1016/j.exppara.2019.04.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2018] [Revised: 03/09/2019] [Accepted: 04/12/2019] [Indexed: 01/28/2023]
Abstract
In the present study, we investigated the in vitro and in vivo leishmanicidal activity of synthetic compounds, containing a semicarbazone scaffold as a peptide mimetic framework. The leishmanicidal effect against amastigotes of Leishmania amazonensis was also evaluated at concentration of 100 μM-0.01 nM. The derivatives 2e, 2f, 2g and 1g, beyond the standards miltefosine and pentamidine, significantly diminished the number of L. amazonensis amastigotes in macrophages. These derivatives were also active against amastigotes of L. braziliensis. As 2g presented potent leishmanicidal activity against the amastigotes of L. amazonensis in macrophages, we also investigated the in vivo leishmanicidal activity of this compound against L. amazonensis. Approximately 105L. amazonensis promastigotes were subcutaneously inoculated into the dermis of the right ear of BALB/c mice, which were subsequently treated with 2g (p.o. or i.p.), miltefosine (p.o.) or glucantime (i.p.) at 30 μmol/kg/day x 28 days. Thus, a similar reduction in the lesion size was observed after the administration of 2g through oral (63.7 ± 10.1%) and intraperitoneal (61.8 ± 3.7%) routes. A larger effect was observed after treatment with miltefosine (97.7 ± 0.4%), and glucantime did not exhibit activity at the dose administered. With respect to the ear parasite load, 2g diminished the number of parasites by p.o. (30.5 ± 5.1%) and i.p. (33.3 ± 4.3%) administration. In addition, 2g induced in vitro apoptosis, autophagy and cell cycle alterations on L. amazonensis promastigotes. In summary, the derivative 2g might represent a lead candidate for antileishmanial drugs, as this compound displayed pronounced leishmanicidal activity.
Collapse
|
10
|
Silva BN, Sales Junior PA, Romanha AJ, Murta SM, Lima CH, Albuquerque MG, D'Elia E, Rodrigues JG, Ferreira VF, Silva FC, Pinto AC, Silva BV. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking. Med Chem 2019; 15:240-256. [DOI: 10.2174/1573406414666180912120502] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Revised: 07/09/2018] [Accepted: 08/22/2018] [Indexed: 01/17/2023]
Abstract
Background:
Chagas disease, also known as American trypanosomiasis, is classified as
one of the 17 most important neglected diseases by the World Health Organization. The only drugs
with proven efficacy against Chagas disease are benznidazole and nifurtimox, however both show
adverse effects, poor clinical efficacy, and development of resistance. For these reasons, the search
for new effective chemical entities is a challenge to research groups and the pharmaceutical industry.
Objective:
Synthesis and evaluation of antitrypanosomal activities of a series of thiosemicarbazones
and semicarbazones containing 1,2,3-1H triazole isatin scaffold.
Method:
5&'-(4-alkyl/aryl)-1H-1,2,3-triazole-isatins were prepared by Huisgen 1,3-dipolar
cycloaddition and the thiosemicarbazones and semicarbazones were obtained by the 1:1 reactions
of the carbonylated derivatives with thiosemicarbazide and semicarbazide hydrochloride,
respectively, in methanol, using conventional reflux or microwave heating. The compounds were
assayed for in vitro trypanocidal activity against Trypanosoma cruzi, the aetiological agent of
Chagas disease. Beyond the thio/semicarbazone derivatives, isatin and triazole synthetic
intermediates were also evaluated for comparison.
Results:
A series of compounds were prepared in good yields. Among the 37 compounds evaluated,
18 were found to be active, in particular thiosemicarbazones containing a non-polar saturated
alkyl chain (IC50 = 24.1, 38.6, and 83.2 &µM; SI = 11.6, 11.8, and 14.0, respectively). To further
elucidate the mechanism of action of these new compounds, the redox behaviour of some active
and inactive derivatives was studied by cyclic voltammetry. Molecular docking studies were also
performed in two validated protein targets of Trypanosoma cruzi, i.e., cruzipain (CRZ) and phosphodiesterase
C (TcrPDEC).
Conclusion:
A class of thio/semicarbazones structurally simple and easily accessible was synthesized.
Compounds containing thiosemicarbazone moieties showed the best results in the series, being
more active than the corresponding semicarbazones. Our results indicated that the activity of
these compounds does not originate from an oxidation-reduction pathway but probably from the
interactions with trypanosomal enzymes.
Collapse
Affiliation(s)
- Bianca N.M. Silva
- Instituto de Quimica (IQ), Universidade Federal do Rio de Janeiro (UFRJ), Av. Athos da Silveira Ramos, 149, Cidade Universitaria, Ilha do Fundao, 21949-900, Rio de Janeiro, RJ, Brazil
| | - Policarpo A. Sales Junior
- Centro de Pesquisas Rene Rachou (CPqRR), Fundacao Oswaldo Cruz (FIOCRUZ), Av. Augusto de Lima, 1715, Barro Preto, 30190-002, Belo Horizonte, MG, Brazil
| | - Alvaro J. Romanha
- Centro de Pesquisas Rene Rachou (CPqRR), Fundacao Oswaldo Cruz (FIOCRUZ), Av. Augusto de Lima, 1715, Barro Preto, 30190-002, Belo Horizonte, MG, Brazil
| | - Silvane M.F. Murta
- Centro de Pesquisas Rene Rachou (CPqRR), Fundacao Oswaldo Cruz (FIOCRUZ), Av. Augusto de Lima, 1715, Barro Preto, 30190-002, Belo Horizonte, MG, Brazil
| | - Camilo H.S. Lima
- Faculdade de Farmacia (FF), Universidade Federal Fluminense (UFF), R. Mario Viana, 523, Santa Rosa, 24241- 000, Niteroi, RJ, Brazil
| | - Magaly G. Albuquerque
- Instituto de Quimica (IQ), Universidade Federal do Rio de Janeiro (UFRJ), Av. Athos da Silveira Ramos, 149, Cidade Universitaria, Ilha do Fundao, 21949-900, Rio de Janeiro, RJ, Brazil
| | - Eliane D'Elia
- Instituto de Quimica (IQ), Universidade Federal do Rio de Janeiro (UFRJ), Av. Athos da Silveira Ramos, 149, Cidade Universitaria, Ilha do Fundao, 21949-900, Rio de Janeiro, RJ, Brazil
| | - José G.A. Rodrigues
- Instituto de Quimica (IQ), Universidade Federal do Rio de Janeiro (UFRJ), Av. Athos da Silveira Ramos, 149, Cidade Universitaria, Ilha do Fundao, 21949-900, Rio de Janeiro, RJ, Brazil
| | - Vitor F. Ferreira
- Instituto de Quimica (IQ), Universidade Federal Fluminense (UFF), 24020-141 Niteroi, RJ, Brazil
| | - Fernando C. Silva
- Instituto de Quimica (IQ), Universidade Federal Fluminense (UFF), 24020-141 Niteroi, RJ, Brazil
| | - Angelo C. Pinto
- Instituto de Quimica (IQ), Universidade Federal do Rio de Janeiro (UFRJ), Av. Athos da Silveira Ramos, 149, Cidade Universitaria, Ilha do Fundao, 21949-900, Rio de Janeiro, RJ, Brazil
| | - Bárbara V. Silva
- Instituto de Quimica (IQ), Universidade Federal do Rio de Janeiro (UFRJ), Av. Athos da Silveira Ramos, 149, Cidade Universitaria, Ilha do Fundao, 21949-900, Rio de Janeiro, RJ, Brazil
| |
Collapse
|
11
|
Ma J, Ni X, Gao Y, Huang K, Wang Y, Liu J, Gong G. Semicarbazone Derivatives Bearing Phenyl Moiety: Synthesis, Anticancer Activity, Cell Cycle, Apoptosis-Inducing and Metabolic Stability Study. Chem Pharm Bull (Tokyo) 2019; 67:351-360. [PMID: 30674756 DOI: 10.1248/cpb.c18-00738] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
A series of semicarbazone derivatives bearing phenyl moiety were synthesized and evaluated for the vitro anticancer activities in four human cancer cell lines (human colon cancer (HT29), human neuro-blastoma (SK-N-SH), human breast cancer (MDA-MB-231), and human gastric cancer (MKN45)). Biological evaluation led to the identification of 11q and 11s, which showed excellent anticancer activities against tested cancer cell lines with IC50 values ranging from 0.32 to 1.57 µM, respectively, while exhibiting weak cytotoxicity on the normal cells (human umbilical vein endothelial cell (HUVEC)). Flow cytometric assay for cell cycle and apoptosis revealed that 11q and 11s caused an arrest in the Sub-G1 cell cycle and inhibited proliferation of cancer cells by inducing apoptosis in a dose-dependent manner. Further enzymatic assay suggested that 11q and 11s could significantly activated procaspase-3 to caspase-3. Metabolic stability study indicated that 11q and 11s showed moderate stability in vitro in human and rat liver microsomes. In view of promising pharmacological activities of 11q and 11s, which had emerged as the valuable lead for further development in the treatment for cancer.
Collapse
Affiliation(s)
| | - Xin Ni
- Medical College, Huaqiao University
| | - Yali Gao
- Pharmacy Department, the Second Affiliated Hospital of Fujian Medical University
| | | | - Yu Wang
- Medical College, Huaqiao University
| | - Jiaan Liu
- Department of Chemistry, University of Massachusetts-Amherst
| | - Guowei Gong
- Department of Pharmaceutical Sciences, Zunyi Medical College Zhuhai Campus
| |
Collapse
|
12
|
Moraes BS, Azeredo FJ, Izoton JC, Amaral M, Barreiro EDJ, Freddo RJ, Dalla Costa T, Lima LM, Haas SE. Leishmanicidal candidate LASSBio-1736, a cysteine protease inhibitor with favorable pharmacokinetics: low clearance and good distribution. Xenobiotica 2017; 48:1258-1267. [DOI: 10.1080/00498254.2017.1405465] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Barbra Sanches Moraes
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Pampa , Uruguaiana , Brazil ,
| | | | - Jessica Cristina Izoton
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Pampa , Uruguaiana , Brazil ,
| | - Marina Amaral
- Laboratório de Avaliação e Síntese de Substâncias Bioativas, Universidade Federal do Rio de Janeiro , Rio de Janeiro , Brazil ,
| | - Eliezer de Jesus Barreiro
- Laboratório de Avaliação e Síntese de Substâncias Bioativas, Universidade Federal do Rio de Janeiro , Rio de Janeiro , Brazil ,
| | | | - Teresa Dalla Costa
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul , Porto Alegre , Brazil
| | - Lídia Moreira Lima
- Laboratório de Avaliação e Síntese de Substâncias Bioativas, Universidade Federal do Rio de Janeiro , Rio de Janeiro , Brazil ,
| | - Sandra Elisa Haas
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Pampa , Uruguaiana , Brazil ,
- Curso Farmácia, Universidade Federal do Pampa , Uruguaiana , Brazil , and
| |
Collapse
|
13
|
Barbosa ASL, Guedes JDS, da Silva DR, Meneghetti SMP, Meneghetti MR, da Silva AE, de Araujo MV, Alexandre-Moreira MS, de Aquino TM, de Siqueira Junior JP, de Araújo RSA, da Cruz RMD, Mendonça-Junior FJB. Synthesis and evaluation of the antibiotic and adjuvant antibiotic potential of organotin(IV) derivatives. J Inorg Biochem 2017; 180:80-88. [PMID: 29247870 DOI: 10.1016/j.jinorgbio.2017.12.004] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2017] [Revised: 12/04/2017] [Accepted: 12/05/2017] [Indexed: 12/31/2022]
Abstract
A series of organotin(IV) derivatives was investigated in vitro for their antibiotic and adjuvant antibiotic properties (efflux pump inhibitors) against Staphylococcus aureus strains that overexpress efflux pump proteins for norfloxacin (SA-1199B), erythromycin (RN-4220) and tetracycline (IS-58). Most organotin(IV) compounds showed significant antibacterial activity with small Minimum Inhibitory Concentration (MIC) values, some of which were close to 1.0μg/mL (3.1μM), but this feature was also associated with substantial cytotoxicity. Nevertheless, the cytotoxicity of these organotin(IV) compounds can be overcome when they are used as antibiotic adjuvants. Their remarkable adjuvant antibiotic properties allow potentiation of the action of tetracycline (against IS-58 strain) by up to 128-fold. This likely indicates that they can act as putative inhibitors of bacterial efflux pumps. These results reinforce organotin(IV) complexes as promising antibacterial agents, and many of these complexes, if associated with antibiotics, can act as potential adjuvant antibiotic candidates.
Collapse
Affiliation(s)
- Ana Soraya Lima Barbosa
- Group of Catalysis and Chemical Reactivity, Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970 Maceió, AL, Brazil
| | - Jéssica de Siqueira Guedes
- Group of Catalysis and Chemical Reactivity, Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970 Maceió, AL, Brazil
| | - Douglas Rozendo da Silva
- Group of Catalysis and Chemical Reactivity, Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970 Maceió, AL, Brazil
| | - Simoni Margareti Plentz Meneghetti
- Group of Catalysis and Chemical Reactivity, Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970 Maceió, AL, Brazil
| | - Mario Roberto Meneghetti
- Group of Catalysis and Chemical Reactivity, Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970 Maceió, AL, Brazil.
| | - Amanda Evelyn da Silva
- Laboratory of Pharmacology and Immunity, Institute of Biological Sciences and Health, Federal University of Alagoas, 57020-720 Maceió, AL, Brazil
| | - Morgana Vital de Araujo
- Laboratory of Pharmacology and Immunity, Institute of Biological Sciences and Health, Federal University of Alagoas, 57020-720 Maceió, AL, Brazil
| | - Magna Suzana Alexandre-Moreira
- Laboratory of Pharmacology and Immunity, Institute of Biological Sciences and Health, Federal University of Alagoas, 57020-720 Maceió, AL, Brazil
| | - Thiago Mendonça de Aquino
- Group of Catalysis and Chemical Reactivity, Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970 Maceió, AL, Brazil; Nucleus of Analysis and Research in Nuclear Magnetic Resonance - NAPRMN, Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57020-720 Maceió, AL, Brazil
| | | | - Rodrigo Santos Aquino de Araújo
- Laboratory of Synthesis and Drug Delivery, Biological Science Department, State University of Paraiba, 58071-160 João Pessoa, PB, Brazil
| | - Ryldene Marques Duarte da Cruz
- Graduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraiba, 58071-160 João Pessoa, PB, Brazil
| | - Francisco Jaime Bezerra Mendonça-Junior
- Laboratory of Synthesis and Drug Delivery, Biological Science Department, State University of Paraiba, 58071-160 João Pessoa, PB, Brazil; Graduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraiba, 58071-160 João Pessoa, PB, Brazil.
| |
Collapse
|
14
|
Taha M, Ismail NH, Imran S, Anouar EH, Selvaraj M, Jamil W, Ali M, Kashif SM, Rahim F, Khan KM, Adenan MI. Synthesis and molecular modelling studies of phenyl linked oxadiazole-phenylhydrazone hybrids as potent antileishmanial agents. Eur J Med Chem 2016; 126:1021-1033. [PMID: 28012342 DOI: 10.1016/j.ejmech.2016.12.019] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2016] [Revised: 12/06/2016] [Accepted: 12/09/2016] [Indexed: 01/24/2023]
Abstract
Molecular hybridization yielded phenyl linked oxadiazole-benzohydrazones hybrids 6-35 and were evaluated for their antileishmanial potentials. Compound 10, a 3,4-dihydroxy analog with IC50 value of 0.95 ± 0.01 μM, was found to be the most potent antileishmanial agent (7 times more active) than the standard drug pentamidine (IC50 = 7.02 ± 0.09 μM). The current series 6-35 conceded in the identification of thirteen (13) potent antileishmanial compounds with the IC50 values ranging between 0.95 ± 0.01-78.6 ± 1.78 μM. Molecular docking analysis against pteridine reductase (PTR1) were also performed to probe the mode of action. Selectivity index showed that compounds with higher number of hydroxyl groups have low selectivity index. Theoretical stereochemical assignment was also done for certain derivatives by using density functional calculations.
Collapse
Affiliation(s)
- Muhammad Taha
- Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA (UiTM), Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia; Faculty of Applied Science UiTM, 40450 Shah Alam, Selangor, Malaysia.
| | - Nor Hadiani Ismail
- Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA (UiTM), Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia; Faculty of Applied Science UiTM, 40450 Shah Alam, Selangor, Malaysia
| | - Syahrul Imran
- Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA (UiTM), Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia; Faculty of Applied Science UiTM, 40450 Shah Alam, Selangor, Malaysia
| | - El Hassane Anouar
- Chemistry Department, College of Sciences and Humanities, Prince Sattam bin Abdulaziz University, Saudi Arabia
| | - Manikandan Selvaraj
- Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia; Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia
| | - Waqas Jamil
- Institute of Advance Research Studies in Chemical Sciences, University of Sindh Jamshoro, 76080 Hyderabad, Pakistan
| | - Muhammad Ali
- Department of Chemistry, COMSATS Institute of Information Technology, University Road, Abbottbad 22060, KPK, Pakistan
| | - Syed Muhammad Kashif
- Institute of Advance Research Studies in Chemical Sciences, University of Sindh Jamshoro, 76080 Hyderabad, Pakistan
| | - Fazal Rahim
- Depatment of Chemistry, Hazara University, Mansehra, Pakistan
| | - Khalid Mohammed Khan
- H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan
| | - Mohd Ilham Adenan
- Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA (UiTM), Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia; Faculty of Applied Science UiTM, 40450 Shah Alam, Selangor, Malaysia
| |
Collapse
|
15
|
Li M, Wang Y, Zhang J, Xie S, Wang C, Wu Y. Synthesis and Biological Evaluation of Novel Aromatic Imide-Polyamine Conjugates. Molecules 2016; 21:molecules21121637. [PMID: 27916902 PMCID: PMC6273765 DOI: 10.3390/molecules21121637] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2016] [Revised: 11/17/2016] [Accepted: 11/23/2016] [Indexed: 11/16/2022] Open
Abstract
Three types of conjugates in which aromatic imide scaffolds were coupled to diverse amine/polyamine motifs were synthesized, and their antitumor activities were evaluated in vitro and in vivo. Results showed that the conjugate 11e of 1,8-naphthilimide with spermine had pronounced effects on inhibiting tumor cell proliferation and inducing tumor cell apoptosis via ROS-mediated mitochondrial pathway. The in vivo assays on three H22 tumor transplant models revealed that compound 11e exerted potent ability in preventing lung cancer metastasis and extending lifespan. Furthermore, the efficacy of 11e in inhibiting tumor growth and improving body weight index were better than that of positive control, amonafide. Our study demonstrates that compound 11e is a valuable lead compound for further investigation.
Collapse
Affiliation(s)
- Ming Li
- Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.
- Pharmaceutical College, Henan University, Kaifeng 475001, China.
| | - Yuxia Wang
- College of Chemistry and Chemical Engineering, Henan University, Kaifeng 475001, China.
| | - Jianying Zhang
- Pharmaceutical College, Henan University, Kaifeng 475001, China.
| | - Songqiang Xie
- Pharmaceutical College, Henan University, Kaifeng 475001, China.
| | - Chaojie Wang
- Key Laboratory of Natural Medicine and Immuno-Engineering, Kaifeng 475001, China.
| | - Yingliang Wu
- Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.
| |
Collapse
|
16
|
Zapata-Sudo G, da Costa Nunes IK, Araujo JSC, da Silva JS, Trachez MM, da Silva TF, da Costa FP, Sudo RT, Barreiro EJ, Lima LM. Synthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazones designed as anti-diabetic agents. DRUG DESIGN DEVELOPMENT AND THERAPY 2016; 10:2869-2879. [PMID: 27672310 PMCID: PMC5024769 DOI: 10.2147/dddt.s108327] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Neuropathy is a serious complication of diabetes that has a significant socioeconomic impact, since it frequently demands high levels of health care consumption and compromises labor productivity. Recently, LASSBio-1471 (3) was demonstrated to improve oral glucose tolerance, reduce blood glucose levels, and display an anti-neuropathy effect in a murine streptozotocin-induced diabetes model. In the present work, we describe the design, synthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazone derivatives (referred to herein as compounds 4–9), which were designed by molecular modification based on the structure of the prototype LASSBio-1471 (3). Among the compounds tested, better plasma stability was observed with 4, 5, and 9 in comparison to compounds 6, 7, and 8. LASSBio-1773 (7), promoted not only hypoglycemic activity but also the reduction of thermal hyperalgesia and mechanical allodynia in a murine model of streptozotocin-induced diabetic neuropathic pain.
Collapse
Affiliation(s)
- Gisele Zapata-Sudo
- National Institute of Science and Technology on Drugs and Medicines, Federal University of Rio de Janeiro, Laboratory of Evaluation and Synthesis of Bioactive Compounds, Center of Health Sciences, Rio de Janeiro, Brazil; Program of Research in Drug Development, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Isabelle Karine da Costa Nunes
- Program of Research in Drug Development, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Josenildo Segundo Chaves Araujo
- National Institute of Science and Technology on Drugs and Medicines, Federal University of Rio de Janeiro, Laboratory of Evaluation and Synthesis of Bioactive Compounds, Center of Health Sciences, Rio de Janeiro, Brazil; Program of Research in Drug Development, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Jaqueline Soares da Silva
- Program of Research in Drug Development, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Margarete Manhães Trachez
- Program of Research in Drug Development, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Department of Anesthesiology, Fluminense Federal University, Rio de Janeiro, Brazil
| | - Tiago Fernandes da Silva
- National Institute of Science and Technology on Drugs and Medicines, Federal University of Rio de Janeiro, Laboratory of Evaluation and Synthesis of Bioactive Compounds, Center of Health Sciences, Rio de Janeiro, Brazil
| | - Filipe P da Costa
- Program of Research in Drug Development, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Roberto Takashi Sudo
- National Institute of Science and Technology on Drugs and Medicines, Federal University of Rio de Janeiro, Laboratory of Evaluation and Synthesis of Bioactive Compounds, Center of Health Sciences, Rio de Janeiro, Brazil; Program of Research in Drug Development, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Eliezer J Barreiro
- National Institute of Science and Technology on Drugs and Medicines, Federal University of Rio de Janeiro, Laboratory of Evaluation and Synthesis of Bioactive Compounds, Center of Health Sciences, Rio de Janeiro, Brazil; Program of Research in Drug Development, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Lídia Moreira Lima
- National Institute of Science and Technology on Drugs and Medicines, Federal University of Rio de Janeiro, Laboratory of Evaluation and Synthesis of Bioactive Compounds, Center of Health Sciences, Rio de Janeiro, Brazil; Program of Research in Drug Development, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| |
Collapse
|
17
|
Rodriguez JB, Falcone BN, Szajnman SH. Detection and treatment ofTrypanosoma cruzi: a patent review (2011-2015). Expert Opin Ther Pat 2016; 26:993-1015. [DOI: 10.1080/13543776.2016.1209487] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
18
|
Di Pietro O, Vicente-García E, Taylor MC, Berenguer D, Viayna E, Lanzoni A, Sola I, Sayago H, Riera C, Fisa R, Clos MV, Pérez B, Kelly JM, Lavilla R, Muñoz-Torrero D. Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity. Eur J Med Chem 2015; 105:120-37. [PMID: 26479031 PMCID: PMC4638191 DOI: 10.1016/j.ejmech.2015.10.007] [Citation(s) in RCA: 49] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2015] [Revised: 09/28/2015] [Accepted: 10/06/2015] [Indexed: 11/28/2022]
Abstract
Human African trypanosomiasis (HAT), Chagas disease and leishmaniasis, which are caused by the trypanosomatids Trypanosoma brucei, Trypanosoma cruzi and Leishmania species, are among the most deadly neglected tropical diseases. The development of drugs that are active against several trypanosomatids is appealing from a clinical and economic viewpoint, and seems feasible, as these parasites share metabolic pathways and hence might be treatable by common drugs. From benzonapthyridine 1, an inhibitor of acetylcholinesterase (AChE) for which we have found a remarkable trypanocidal activity, we have designed and synthesized novel benzo[h][1,6]naphthyridines, pyrrolo[3,2-c]quinolines, azepino[3,2-c]quinolines, and pyrano[3,2-c]quinolines through 2–4-step sequences featuring an initial multicomponent Povarov reaction as the key step. To assess the therapeutic potential of the novel compounds, we have evaluated their in vitro activity against T. brucei, T. cruzi, and Leishmania infantum, as well as their brain permeability, which is of specific interest for the treatment of late-stage HAT. To assess their potential toxicity, we have determined their cytotoxicity against rat myoblast L6 cells and their AChE inhibitory activity. Several tricyclic heterofused quinoline derivatives were found to display an interesting multi-trypanosomatid profile, with one-digit micromolar potencies against two of these parasites and two-digit micromolar potency against the other. Pyranoquinoline 39, which displays IC50 values of 1.5 μM, 6.1 μM and 29.2 μM against T. brucei, L. infantum and T. cruzi, respectively, brain permeability, better drug-like properties (lower lipophilicity and molecular weight and higher CNS MPO desirability score) than hit 1, and the lowest AChE inhibitory activity of the series (IC50 > 30 μM), emerges as an interesting multi-trypanosomatid lead, amenable to further optimization particularly in terms of its selectivity index over mammalian cells. Novel classes of tricyclic heterofused quinolines have been synthesized. Their 2–4-step syntheses involve a multicomponent Povarov reaction as the key step. Some compounds exhibit single digit micromolar potencies against 2 trypanosomatids. All compounds with multi-trypanosomatid activity can cross the blood–brain barrier. Most compounds with multi-trypanosomatid activity have drug like properties.
Collapse
Affiliation(s)
- Ornella Di Pietro
- Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Facultat de Farmàcia, and Institut de Biomedicina (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain
| | | | - Martin C Taylor
- Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom
| | - Diana Berenguer
- Laboratori de Parasitologia, Departament de Microbiologia i Parasitologia Sanitàries, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain
| | - Elisabet Viayna
- Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Facultat de Farmàcia, and Institut de Biomedicina (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain
| | - Anna Lanzoni
- Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Facultat de Farmàcia, and Institut de Biomedicina (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain
| | - Irene Sola
- Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Facultat de Farmàcia, and Institut de Biomedicina (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain
| | - Helena Sayago
- Barcelona Science Park, Baldiri Reixac, 10-12, E-08028, Barcelona, Spain
| | - Cristina Riera
- Laboratori de Parasitologia, Departament de Microbiologia i Parasitologia Sanitàries, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain
| | - Roser Fisa
- Laboratori de Parasitologia, Departament de Microbiologia i Parasitologia Sanitàries, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain
| | - M Victòria Clos
- Departament de Farmacologia, de Terapèutica i de Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, E-08193, Bellaterra, Barcelona, Spain
| | - Belén Pérez
- Departament de Farmacologia, de Terapèutica i de Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, E-08193, Bellaterra, Barcelona, Spain
| | - John M Kelly
- Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom
| | - Rodolfo Lavilla
- Barcelona Science Park, Baldiri Reixac, 10-12, E-08028, Barcelona, Spain; Laboratori de Química Orgànica, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain
| | - Diego Muñoz-Torrero
- Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Facultat de Farmàcia, and Institut de Biomedicina (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain.
| |
Collapse
|